Seoul, May 7 (IANS) The Korea Biotechnology Industry Organization (KBIO) on Wednesday said it has requested the US to exempt South Korea from the Donald Trump administration’s plan to impose tariffs on pharmaceutical imports.
KBIO said it submitted such an opinion formally to the US Department of Commerce on Tuesday (US time) regarding an ongoing investigation under Section 232 of the Trade Expansion Act, which is examining the national security implications of pharmaceutical imports, Yonhap news agency reported.
Washington launched the probe on April 1 and has sought public input from stakeholders. US President Trump has said he will announce tariff measures on pharmaceuticals in the coming weeks.
The organisation emphasised that South Korea is a reliable partner in the US pharmaceutical supply chain and plays a key role in making high-cost prescription drugs more affordable.
Citing recommendations by the US National Security Commission on Emerging Biotechnology last month, the South Korean bio trade group noted that the commission had stressed the importance of collaborating with allied countries to stabilise the pharmaceutical supply chain.
KBIO stressed that South Korea is already contributing to the US drug ecosystem through new drug development and contract manufacturing.
“Pharmaceutical products are essential for national security and patient protection, and global supply chains are highly interdependent,” the association said. “If trade measures are deemed necessary, we ask that South Korea, a key US ally and trusted source, be exempted from such actions.”
Meanwhile, South Korea has also asked the US to make “special consideration” of its chip exports as the Trump administration is moving to impose tariffs on imported semiconductors, Seoul’s industry ministry said Wednesday.
The South Korean government submitted a written opinion to the US administration regarding Washington’s national security investigation into semiconductor imports under the US Trade Expansion Act, according to the Ministry of Trade, Industry and Energy, Yonhap reported.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
